Hyaluronic Acid is Anti-Cancer — If You Take the Right Kind
- © Nils Osmar 2025. Published October 10, 2025
- This post is not intended as, and should not be taken as, medical advice.
- See full Medical Disclaimer
by Nils Osmar. With thanks to Claude.ai, Perplexity.ai and Hailuo.ai
Hyaluronic acid (HA) is a natural sugar molecule found throughout our bodies—in our skin, joints, eyes, and the spaces between our cells. It’s best known in cosmetics for its ability to retain moisture, but scientists have discovered it plays a surprisingly complex role in cancer development that depends entirely on the size of the HA molecules.
Size Matters
HA molecules vary in size, measured by their molecular weight. Think of them like chains made of repeating sugar units—some chains are very long, others are broken into shorter fragments. These different sizes have dramatically different effects on cancer:
High-Molecular-Weight HA (HMW-HA): The Protector
Large, intact HA molecules appear to protect against cancer. Research shows HMW-HA works by:
- Activating tumor suppressor genes: HMW-HA stimulates cellular pathways that turn on p16ink4a, a gene acting as a brake on cancer development.
- Preserving tissue integrity: These large molecules help keep tissues structurally organized, which makes it harder for cancer cells to invade.
- Reducing inflammation: HMW-HA has anti-inflammatory effects, important because chronic inflammation can promote cancer.
One of the most interesting examples comes from the naked mole-rat, a small rodent that almost never gets cancer. These animals produce exceptionally large HA molecules (6-12 million Daltons, compared to 0.5-3 million in humans), and researchers believe this is likely a key factor in their remarkable cancer resistance. In mouse studies, increasing ultra-high-molecular-weight HA production is associated with improved healthspan and significantly longer lifespan.
Low-Molecular-Weight HA (LMW-HA): The Risk Factor
When large HA molecules break down into smaller fragments—which happens during tissue injury, inflammation, or in cancerous tissues—the effect reverses. These LMW-HA fragments generally promote cancer progression through several mechanisms:
- Promoting inflammation: LMW-HA triggers inflammatory responses by activating immune receptors like TLR-2 and TLR-4, creating an environment that supports tumor growth.
- Enhancing cancer cell movement: These fragments ramp up enzymes called matrix metalloproteases that help cancer cells break through tissue barriers and spread.
- Facilitating metastasis: LMW-HA can disrupt lymphatic vessels—part of the body’s drainage system—making it easier for cancer cells to escape into the bloodstream and spread.
- Stimulating blood vessel formation: LMW-HA encourages angiogenesis, the growth of new blood vessels tumors need to grow.
Clinical studies back these findings. For example, in breast cancer patients, higher blood levels of LMW-HA—but not total HA—correlated with lymph node metastasis, suggesting LMW-HA is a better indicator of cancer spread. Similar patterns appear in colorectal cancer, where cancerous tissue shows elevated LMW-HA fragments compared to healthy tissue.
Context Matters Too
While the general rule is that big HA protects and small HA promotes cancer, biology is complex. Some studies find very small HA fragments (called oligosaccharides, just 3-9 sugar units long) can actually slow cancer growth by reducing tumor cell proliferation and stimulating immune responses. Other research shows these tiny fragments may interfere with cancer cell attachment or even trigger cancer cell death.
These seemingly contradictory effects reflect that outcomes depend on the specific size of HA fragments, cancer types, and the many molecules and receptors present in the cellular environment. Most contexts show the LMW-HA fragments promoting cancer, but scientists continue to unravel the full picture.
Why This Happens: The Mechanism
These size-dependent effects arise from how HA interacts with proteins on cell surfaces—especially a protein called CD44. Large HMW-HA molecules bind to CD44 and send “calm down” signals that restrict cell growth and movement. Smaller HA fragments activate different receptors like TLR-2, TLR-4, and RHAMM, or interact with CD44 in ways that trigger inflammation, cell migration, and proliferation—processes cancer cells exploit.
In healthy tissues, HA is continuously produced and broken down in a balanced cycle, which helps maintain tissue hydration and repair. This turnover is controlled by enzymes called hyaluronan synthases (HAS), which build long HA chains, and hyaluronidases (HYAL), which break these chains into smaller pieces. In cancer, this balance gets disrupted: hyaluronidases are often overactive, and inflammatory conditions create reactive oxygen species (ROS) that further fragment HA. The synthesis process may also shift, producing shorter chains more frequently. This disruption leads to an accumulation of LMW-HA fragments in tumors, which then drive inflammation, invasion, and new blood vessel formation, while weakening the protective effects of HMW-HA.
The Bottom Line
Scientific evidence strongly supports that:
- High-molecular-weight HA protects against cancer through multiple mechanisms, including activating tumor suppressors and maintaining tissue structure.
- Low-molecular-weight HA fragments usually promote tumor growth and spread by enhancing inflammation, invasion, and blood vessel creation.
- Very small HA oligomers may have anti-cancer effects in specific settings, highlighting biology’s complexity and context-dependence.
This research opens exciting therapeutic possibilities—could treatments preserve HMW-HA or prevent its breakdown? Could we block the harmful effects of LMW-HA fragments? These questions are actively being explored in labs worldwide.
Note from Nils: What I’m Doing
- I started taking high hyaluronic acid about four years ago because of its benefits in relation to skin aging. The kind I’m currently using is high molecular weight HA product. It was developed by Dr Vera Gorbunova, who has done much of the key research related to this compound as it relates to the aging process.
- I asked Claude AI and perplexity AI to verify the accuracy of the information in this article; for more information, please see the references below.
References
[1] Tian X, et al. (2013). High-molecular mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature, 499:346-349. PMC4414831
[4] Lowry KP, et al. (2022). Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review. International Journal of Molecular Sciences, 24(1):103. PMC9820514
[5] Tolg C, et al. (2018). Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance. International Journal of Molecular Sciences, 19(12):3916. PMC6316154
[6] Chanmee T, et al. (2023). Hyaluronic acid: More than a carrier, having an overpowering extracellular and intracellular impact on cancer. Carbohydrate Polymers. ScienceDirect
[7] Stanford Chemicals Company. (2025). Why Does High Molecular Weight Hyaluronic Acid Matter. Article
[8] Zhao Y, et al. (2023). Evolution of high-molecular-mass hyaluronic acid is associated with subterranean lifestyle. Nature Communications, 14:7666. Nature
[9] Petrey AC, de la Motte CA. (2014). Hyaluronan, a crucial regulator of inflammation. Frontiers in Immunology, 5:101. PMC4414831
[12] Wu M, et al. (2015). A novel role of low molecular weight hyaluronan in breast cancer metastasis. FASEB Journal, 29(4):1290-1298. PubMed
[13] Du Y, et al. (2016). Low-molecular-weight hyaluronan accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion. Oncoimmunology, 5(11):e1232235. PMC5139649
[14] Garantziotis S, Savani RC. (2022). Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression. Frontiers in Immunology, 13:971278. Frontiers
[15] Alaniz L, et al. (2009). Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response. Cancer Letters, 278(1):9-16. PubMed
[16] Du Y, Gao F. (2023). ‘Two-faces’ of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment. Discover Oncology, 14:8. Springer
[18] Chanmee T, et al. (2023). Hyaluronic acid: More than a carrier. Carbohydrate Polymers, 323:121398. ScienceDirect
[19] Tolg C, et al. (2018). Differing Roles of Hyaluronan Molecular Weight. International Journal of Molecular Sciences. PMC6316154
[20] Turley EA, et al. (2019). Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment. Frontiers in Immunology, 10:947. Frontiers
This article summarizes current scientific research on hyaluronic acid and cancer. All sources are peer-reviewed scientific publications accessible through the provided links.
Not medical advice
This article is not intended as, and should not be taken as, medical advice. I’m not advising that people eat any particular diet or take any particular supplement(s), just reporting on what I’m doing. Supplements, like medications and other interventions, can have side effects; I would encourage people to research both possible benefits and side effects before starting on any supplementation regimen, and consult with a medical professional about any issues which might have a medical component. See full Medical Disclaime
Other resources
- My Youtube channel Pathways to Longevity
- My Facebook group: Anti-Aging and Life Extension,
